US$ 25.76
glp-1 drugs and pancreatitis Rising Use of May Be Linked to Rare Cases, Study Finds Studies examining GLP-1 RA therapy
Description
You may have heard of Bydureon, Ozempic, Trulicity, or Victoza

2020;161:S138S146
Check the label or call your provider to confirm

FDA Drug Safety Communication: FDA adds warnings about heart failure risk to labels of type 2 diabetes medicines containing saxagliptin and alogliptin
By aligning with payer priorities and demonstrating the effectiveness and cost-efficiency of their interventions, these companies can position themselves as indispensable partners in the fight against obesity and diabetes

More research is ongoing
